Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Innate Pharma
Biotech
Sanofi hands cancer drug to Innate as it pivots R&D pact focus
Sanofi is handing back a phase 2-stage natural killer cell engager and canceling another cancer trial.
James Waldron
Apr 23, 2025 6:35am
Innate antibody pits NK cells against lymphoma in animal models
Nov 15, 2024 2:00pm
Less than a year in, BenevolentAI CEO is out—Chutes & Ladders
Oct 18, 2024 8:30am
Innate drops monotherapy plans for lacutamab in type of lymphoma
Mar 21, 2024 8:27am
Scorpion taps new CEO, CMO—Chutes & Ladders
Jan 5, 2024 9:30am
Innate secures speedy resolution of FDA hold on lymphoma trials
Jan 4, 2024 9:50am
